ClinicalTrials.gg
CompletedNCT04113876CHRONOHOSPIUpdated Mar 1, 2023

Circadian Health and Influential Factors

An observational study in Chronobiology Disorders, sponsored by Instituto de Salud Carlos III. Completed at 1 site in Spain. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-03-01.

Sponsored by Instituto de Salud Carlos III · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
975
Ages
18 Years and older
Sex
All
01

Study summary

This study evaluates the quality of sleep of patients admitted to medical and intensive care units. All of them will have a clock placed to measure their circadian activity. Also, data will be recorded through questionnaires about the unit, patient habits and medical problems.

Read the detailed description

The investigators found an extensive bibliography related to the quality of sleep and its effects on health. However, it should be noted the literary emptiness in relation to the influential factors in it. Chronobiology is the science responsible for studying the rhythmic changes in living beings; where the investigators include the circadian rhythm. In this way, all the "cycles" will be influenced by a series of factors that allow its correct operation, being in this case the light-dark cycle (LD), together with the temperature compensation, these being the determinants that allow, or not homeostasis.

The sleep - wake pattern is one of the most important circadian rhythms that happen in the organism. The dream is an unconscious process by which, despite the muscular relaxation that occurs, it is accompanied by continuous brain activity along with sensitive perception, where several of the organ systems come into play. This cycle is composed of two factors: a homeostatic one directly proportional to the time we are awake, and another circadian, dependent on the secretion of melatonin and the body's regulation of temperature. This fact can be compromised by the appearance of both external and internal stimuli, altering normal functioning, which is translated into sleep deprivation, which, if extended over time, can have physical and mental consequences, Some of them are: deterioration of the immune function, an increase in the incidence of cardiovascular diseases, memory deficit, early aging, mood swings, difficulty in healing, greater probability of developing metabolic syndromes, cognitive, affective disorders and even some types of cancer

The results obtained will facilitate the elaboration of action protocols focused on improving sleep quality in hospitalized patients.

02

Conditions studied

  • Chronobiology Disorders

Keywords

  • sleep quality
  • circadian rhythm
  • nursing activities
03

In context

Chronobiology Disorders

102 studies on the registry are indexed under Chronobiology Disorders; 22 are open to participants now.

This study's enrollment of 975 is above the median of 80 across 33 observational studies indexed under Chronobiology Disorders.

Browse Chronobiology Disorders studies →

Lead sponsor

Instituto de Salud Carlos III is the lead sponsor of 10 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Users who are part of the study must be adults admitted to intensive care units (ICUs), Medical Units (UMs) and Surgical units (UQs), of the 13 participating hospitals: Andalusia (H. Juan Ramón Jiménez, Huelva), Catalonia (H. Mataró and H. Arnau Villanova, Lleida), Cantabria (HU Marqués Valdecilla), Castilla y León (H. del Bierzo, Ponferrada), Castila-La Mancha (HGU Ciudad Real), C. Madrid (HU 12 de Octubre ), C. Valenciana (HGU Valencia and HGU Alicante), Murcia Region (C H Cartagena, HCU V Arrixaca) and Basque Country (H. Basurto, Bilbao and H. Galdakao-Usansolo, Vizcaya).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • subjects over 18 years of age, minimum duration of the hospitalization process of 96h, conscious and oriented with constancy in their clinical history (HC) and who give their consent.

Exclusion criteria

Exclusion Criteria:

  • personas con discapacidad visual y/o auditiva documentada en su HC, en el caso de los pacientes de Unidades de Cuidados Intensivos (UCIs) se excluirán a aquellos que obtengan una puntuación inferior a 8 en la escala Glasgow. Pacientes con cualquier tipo de aislamiento y aquellos incluidos en el plan de Cuidados Paliativos.
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
975 participants (actual)
Target follow-up
2 Years
Patient registry
Yes
06

What researchers measure

Primary outcomes

  1. Circadian Health

    Using the KRONOHEALTH® recording device, we will measure the following indicators: * Total Sleep Time * Sleep Fragmentations * Sleep depth * Chronobiological health index

    Time frame: 96 hours

Secondary outcomes

  1. Subjective Sleep Quality

    Scores in the Pittsburgh sleep quality index

    Time frame: 1 day (one time evaluation)

  2. Degree of sleep interference during hospitalization

    Visual analogue scale from 0 to 10 points.

    Time frame: 1 day (one time evaluation)

07

Study locations

1 site
  • Teresa Moreno Casbas
    Madrid, 28029, Spain
08

References and documents

Publications

  • Erren TC, Reiter RJ. Revisiting chronodisruption: when the physiological nexus between internal and external times splits in humans. Naturwissenschaften. 2013 Apr;100(4):291-8. doi: 10.1007/s00114-013-1026-5. Epub 2013 Mar 14. PubMed 23494200 ↗
  • Erren TC, Reiter RJ. Defining chronodisruption. J Pineal Res. 2009 Apr;46(3):245-7. doi: 10.1111/j.1600-079X.2009.00665.x. Epub 2009 Feb 9. PubMed 19215573 ↗
  • Garaulet M, Madrid JA. Chronobiological aspects of nutrition, metabolic syndrome and obesity. Adv Drug Deliv Rev. 2010 Jul 31;62(9-10):967-78. doi: 10.1016/j.addr.2010.05.005. Epub 2010 May 24. PubMed 20580916 ↗
  • Saper CB, Scammell TE, Lu J. Hypothalamic regulation of sleep and circadian rhythms. Nature. 2005 Oct 27;437(7063):1257-63. doi: 10.1038/nature04284. PubMed 16251950 ↗
  • Tononi G, Cirelli C. Sleep function and synaptic homeostasis. Sleep Med Rev. 2006 Feb;10(1):49-62. doi: 10.1016/j.smrv.2005.05.002. Epub 2005 Dec 22. PubMed 16376591 ↗
  • Martínez Nicolás AB, Blázquez Manzanera A. La hora de nuestro cuerpo. Monitorización Ambulatoria Circadiana. Revista Eubacteria 2015; 33: 22-28.
  • 8 National Institute of Neurological Disorders and Stroke. (2007). How much sleep do we need? In Brain Basics: Understanding Sleep. [obtenido de: http://bit.ly/2rA34Zk consultado 30 de enero de 2018].
  • da Costa SV, Ceolim MF. [Factors that affect inpatients' quality of sleep]. Rev Esc Enferm USP. 2013 Feb;47(1):46-52. doi: 10.1590/s0080-62342013000100006. Portuguese. PubMed 23515802 ↗
  • Hacker ED, Kapella MC, Park C, Ferrans CE, Larson JL. Sleep Patterns During Hospitalization Following Hematopoietic Stem Cell Transplantation. Oncol Nurs Forum. 2015 Jul;42(4):371-9. doi: 10.1188/15.ONF.371-379. PubMed 26148316 ↗
  • Van Someren EJ, Cirelli C, Dijk DJ, Van Cauter E, Schwartz S, Chee MW. Disrupted Sleep: From Molecules to Cognition. J Neurosci. 2015 Oct 14;35(41):13889-95. doi: 10.1523/JNEUROSCI.2592-15.2015. PubMed 26468189 ↗
  • Cho K, Ennaceur A, Cole JC, Suh CK. Chronic jet lag produces cognitive deficits. J Neurosci. 2000 Mar 15;20(6):RC66. doi: 10.1523/JNEUROSCI.20-06-j0005.2000. PubMed 10704520 ↗
  • Pandi-Perumal SR, Moscovitch A, Srinivasan V, Spence DW, Cardinali DP, Brown GM. Bidirectional communication between sleep and circadian rhythms and its implications for depression: lessons from agomelatine. Prog Neurobiol. 2009 Aug;88(4):264-71. doi: 10.1016/j.pneurobio.2009.04.007. Epub 2009 May 18. PubMed 19454302 ↗
  • Davis S, Mirick DK, Stevens RG. Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst. 2001 Oct 17;93(20):1557-62. doi: 10.1093/jnci/93.20.1557. PubMed 11604479 ↗
  • Kondratov RV. A role of the circadian system and circadian proteins in aging. Ageing Res Rev. 2007 May;6(1):12-27. doi: 10.1016/j.arr.2007.02.003. Epub 2007 Feb 21. PubMed 17369106 ↗
  • Venkateshiah SB, Collop NA. Sleep and sleep disorders in the hospital. Chest. 2012 May;141(5):1337-1345. doi: 10.1378/chest.11-2591. PubMed 22553268 ↗
  • Young JS, Bourgeois JA, Hilty DM, Hardin KA. Sleep in hospitalized medical patients, part 1: factors affecting sleep. J Hosp Med. 2008 Nov-Dec;3(6):473-82. doi: 10.1002/jhm.372. PubMed 19084897 ↗
  • Erren TC, Reiter RJ. Preventing cancers caused by chronodisruption: blocking blue light alone is unlikely to do the trick. Med Hypotheses. 2009 Dec;73(6):1077-8. doi: 10.1016/j.mehy.2009.05.003. Epub 2009 Jun 3. No abstract available. PubMed 19497681 ↗
  • Portas CM, Krakow K, Allen P, Josephs O, Armony JL, Frith CD. Auditory processing across the sleep-wake cycle: simultaneous EEG and fMRI monitoring in humans. Neuron. 2000 Dec;28(3):991-9. doi: 10.1016/s0896-6273(00)00169-0. PubMed 11163282 ↗
  • Halperin D. Environmental noise and sleep disturbances: A threat to health? Sleep Sci. 2014 Dec;7(4):209-12. doi: 10.1016/j.slsci.2014.11.003. Epub 2014 Nov 15. PubMed 26483931 ↗
  • Delaney LJ, Van Haren F, Lopez V. Sleeping on a problem: the impact of sleep disturbance on intensive care patients - a clinical review. Ann Intensive Care. 2015 Feb 26;5:3. doi: 10.1186/s13613-015-0043-2. eCollection 2015. PubMed 25852963 ↗
  • Little A, Ethier C, Ayas N, Thanachayanont T, Jiang D, Mehta S. A patient survey of sleep quality in the Intensive Care Unit. Minerva Anestesiol. 2012 Apr;78(4):406-14. Epub 2012 Feb 15. PubMed 22337154 ↗
  • Carvalho Bos S, Waterhouse J, Edwards B, Simons R, Reilly T. The use of actimetry to assess changes to the rest-activity cycle. Chronobiol Int. 2003 Nov;20(6):1039-59. doi: 10.1081/cbi-120025397. PubMed 14680142 ↗
  • Roenneberg T, Kuehnle T, Juda M, Kantermann T, Allebrandt K, Gordijn M, Merrow M. Epidemiology of the human circadian clock. Sleep Med Rev. 2007 Dec;11(6):429-38. doi: 10.1016/j.smrv.2007.07.005. Epub 2007 Nov 1. PubMed 17936039 ↗
  • Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft W, Pollak CP. The role of actigraphy in the study of sleep and circadian rhythms. Sleep. 2003 May 1;26(3):342-92. doi: 10.1093/sleep/26.3.342. PubMed 12749557 ↗
  • Morgenthaler T, Alessi C, Friedman L, Owens J, Kapur V, Boehlecke B, Brown T, Chesson A Jr, Coleman J, Lee-Chiong T, Pancer J, Swick TJ; Standards of Practice Committee; American Academy of Sleep Medicine. Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007. Sleep. 2007 Apr;30(4):519-29. doi: 10.1093/sleep/30.4.519. PubMed 17520797 ↗
  • Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213. doi: 10.1016/0165-1781(89)90047-4. PubMed 2748771 ↗
  • Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991 Dec;14(6):540-5. doi: 10.1093/sleep/14.6.540. PubMed 1798888 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2019 to primary completion in Dec 2022, 47 months.

Of 19 observational studies under Chronobiology Disorders, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 47. This study's 47 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 6, 2019
First posted
Oct 3, 2019
StartActual
Jan 1, 2019
Primary completionActual
Dec 31, 2022
CompletionActual
Dec 31, 2022
Last update
Mar 1, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 1, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04113876
Lead sponsor
Instituto de Salud Carlos III
Collaborators
Institut de Recerca Biomèdica de Lleida, Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca
Responsible party
Teresa Moreno Casbas (Doctor, Clinical Research, Instituto de Salud Carlos III) — Principal investigator
First posted
Oct 3, 2019
Start date
Jan 1, 2019
Primary completion
Dec 31, 2022
Completion
Dec 31, 2022
Last update
Mar 1, 2023

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion